Abstract

Background: Melasma often presents as a therapeutic challenge to dermatologists. Due to its relapsing nature, long-term topical maintenance therapies are often required which may be time consuming and costly for patients. As a result, light and laser therapies have become increasingly popular in the treatment of melasma. Yet, clinical studies on melasma tend to focus more on the efficacy of these treatments rather than their ability to achieve long-term results. Objective: To assess the ability of light and laser treatments to achieve long lasting results in melasma. Methods: A literature review was conducted to assess the long-term efficacy of laser and light treatments in epidermal, mixed and dermal melasma. Results: Out of 128 articles reviewed, 17 studies of laser and light therapies included patient follow-up without maintenance therapies in their study designs. According to these studies, IPL and Nd:YAG achieved long lasting results for up to 6-months. Studies also suggest that combining these therapies together as well as combining them with other topical or procedural therapies, may result in enhanced long-term efficacy. Despite this, these treatments are less commonly used than topical therapies in clinical practice due to their cost and potential side effects, such as scarring, post inflammatory hyperpigmentation and prolonged erythema. Studies also indicate that these therapies vary in efficacy depending on the melasma subtype. Limitations: There was a lack of standardized outcome assessments. Conclusions: In conclusion, light and laser treatments have a role in treating melasma. To study their efficacy in treating melasma long-term, more studies with extended duration of follow-ups and standardized outcome measures are needed.

Highlights

  • Melasma is a common acquired disorder that is characterized by hyperpigmented macules or patches that tend to occur symmetrically in sun-exposed areas, more frequently in women [1]

  • In conclusion, light and laser treatments have a role in treating melasma

  • Previous studies have suggested that the median time to melasma relapse following cessation of triple combination cream was 58 days [4]

Read more

Summary

Introduction

Melasma is a common acquired disorder that is characterized by hyperpigmented macules or patches that tend to occur symmetrically in sun-exposed areas, more frequently in women [1]. Long-term maintenance therapies are required that may be costly and time consuming. Topical therapies, such as triple combination cream, are currently considered first-line for the treatment of melasma, yet they have marginal efficacy and are typically more beneficial for epidermal type melisma [3]. Though expensive, have become increasingly popular in the treatment of melasma. Due to its relapsing nature, long-term topical maintenance therapies are often required which may be time consuming and costly for patients. Light and laser therapies have become increasingly popular in the treatment of melasma. Clinical studies on melasma tend to focus more on the efficacy of these treatments rather than their ability to achieve long-term results

Methods
Results
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call